These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 17533390)
1. Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma. Lau YS; Adamopoulos IE; Sabokbar A; Giele H; Gibbons CL; Athanasou NA Br J Cancer; 2007 Jun; 96(11):1716-22. PubMed ID: 17533390 [TBL] [Abstract][Full Text] [Related]
2. Malignant melanoma and bone resorption. Lau YS; Sabokbar A; Giele H; Cerundolo V; Hofstetter W; Athanasou NA Br J Cancer; 2006 May; 94(10):1496-503. PubMed ID: 16641914 [TBL] [Abstract][Full Text] [Related]
3. Ewing sarcoma cells express RANKL and support osteoclastogenesis. Taylor R; Knowles HJ; Athanasou NA J Pathol; 2011 Oct; 225(2):195-202. PubMed ID: 21547906 [TBL] [Abstract][Full Text] [Related]
4. Synovial fluid macrophages are capable of osteoclast formation and resorption. Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818 [TBL] [Abstract][Full Text] [Related]
5. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis. Sabokbar A; Kudo O; Athanasou NA J Orthop Res; 2003 Jan; 21(1):73-80. PubMed ID: 12507582 [TBL] [Abstract][Full Text] [Related]
6. RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer. Lau YS; Danks L; Sun SG; Fox S; Sabokbar A; Harris A; Athanasou NA Breast Cancer Res Treat; 2007 Sep; 105(1):7-16. PubMed ID: 17151927 [TBL] [Abstract][Full Text] [Related]
7. Human mesenchymal tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells. Yang TT; Sabokbar A; Gibbons CL; Athanasou NA J Bone Joint Surg Br; 2002 Apr; 84(3):452-6. PubMed ID: 12002510 [TBL] [Abstract][Full Text] [Related]
8. Osteoclast formation and function in pigmented villonodular synovitis. Taylor R; Kashima TG; Knowles H; Gibbons CL; Whitwell D; Athanasou NA J Pathol; 2011 Sep; 225(1):151-6. PubMed ID: 21706481 [TBL] [Abstract][Full Text] [Related]
9. VEGF165 promotes the osteolytic bone destruction of ewing's sarcoma tumors by upregulating RANKL. Guan H; Zhou Z; Cao Y; Duan X; Kleinerman ES Oncol Res; 2009; 18(2-3):117-25. PubMed ID: 20066901 [TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture. Komine M; Kukita A; Kukita T; Ogata Y; Hotokebuchi T; Kohashi O Bone; 2001 May; 28(5):474-83. PubMed ID: 11344046 [TBL] [Abstract][Full Text] [Related]
11. Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages. Itonaga I; Sabokbar A; Murray DW; Athanasou NA Ann Rheum Dis; 2000 Jan; 59(1):26-31. PubMed ID: 10627423 [TBL] [Abstract][Full Text] [Related]
12. VEGF, FLT3 ligand, PlGF and HGF can substitute for M-CSF to induce human osteoclast formation: implications for giant cell tumour pathobiology. Taylor RM; Kashima TG; Knowles HJ; Athanasou NA Lab Invest; 2012 Oct; 92(10):1398-406. PubMed ID: 22906984 [TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. Kobayashi K; Takahashi N; Jimi E; Udagawa N; Takami M; Kotake S; Nakagawa N; Kinosaki M; Yamaguchi K; Shima N; Yasuda H; Morinaga T; Higashio K; Martin TJ; Suda T J Exp Med; 2000 Jan; 191(2):275-86. PubMed ID: 10637272 [TBL] [Abstract][Full Text] [Related]
14. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456 [TBL] [Abstract][Full Text] [Related]
15. CD14- mononuclear stromal cells support (CD14+) monocyte-osteoclast differentiation in aneurysmal bone cyst. Taylor RM; Kashima TG; Hemingway FK; Dongre A; Knowles HJ; Athanasou NA Lab Invest; 2012 Apr; 92(4):600-5. PubMed ID: 22330339 [TBL] [Abstract][Full Text] [Related]
16. Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis. Hirayama T; Danks L; Sabokbar A; Athanasou NA Rheumatology (Oxford); 2002 Nov; 41(11):1232-9. PubMed ID: 12421995 [TBL] [Abstract][Full Text] [Related]
17. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644 [TBL] [Abstract][Full Text] [Related]
18. Human tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells. Quinn JM; McGee JO; Athanasou NA J Pathol; 1998 Jan; 184(1):31-6. PubMed ID: 9582524 [TBL] [Abstract][Full Text] [Related]
19. Arthroplasty membrane-derived fibroblasts directly induce osteoclast formation and osteolysis in aseptic loosening. Sabokbar A; Itonaga I; Sun SG; Kudo O; Athanasou NA J Orthop Res; 2005 May; 23(3):511-9. PubMed ID: 15885469 [TBL] [Abstract][Full Text] [Related]
20. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]